Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7759/cureus.10095 http://scihub22266oqcxt.onion/10.7759/cureus.10095 33005516!7522179!33005516     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33005516&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Cureus 2020 ; 12 (8): e10095 Nephropedia Template TP {{tp|p=33005516|t=2020. COVID-19 Associated Coagulopathy in the Setting of Underlying Malignancy |pdf=|usr=}}{{33005516}} gab.com Text COVID-19 Associated Coagulopathy in the Setting of Underlying Malignancy JO: Cureus http://www.kidney.de/pget.php?&tw=1&pmid=33005516 #FOAvip Coronavirus disease 2019 (COVID-19) associated coagulopathy is a well-recognized predictor for morbidity and mortality in COVID-19 patients. Both deep vein thrombosis (DVT) and pulmonary embolism (PE) have been reported in COVID-19 patients. Nonetheless, there are no consensus guidelines on the use of therapeutic coagulation in this group of patients. We herein present a unique case of a confirmed COVID-19 patient with metastatic ovarian cancer who presented with DVT and PE despite being on therapeutic anticoagulation, highlighting the unpredictability of COVID-19 associated coagulopathy. This case study raises the awareness that the thrombophilic state in metastatic malignancies is potentially augmented by COVID-19. We also discuss the complexity of making anticoagulation treatment decision in COVID-19 patients in the absence of evidence-based guidelines. Twit Text FOAVip COVID-19 Associated Coagulopathy in the Setting of Underlying Malignancy ????Cureus http://www.kidney.de/pget.php?&tw=1&pmid=33005516 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33005516 #FOAvip English Wikipedia <ref>{{Cite pmid|33005516}}</ref> COVID-19 Associated Coagulopathy in the Setting of Underlying Malignancy #MMPMID33005516 Lim SL; Chan KH; Slim J; Guron G; Shaaban HS Cureus 2020[Aug]; 12 (8): e10095 PMID33005516show ga Coronavirus disease 2019 (COVID-19) associated coagulopathy is a well-recognized predictor for morbidity and mortality in COVID-19 patients. Both deep vein thrombosis (DVT) and pulmonary embolism (PE) have been reported in COVID-19 patients. Nonetheless, there are no consensus guidelines on the use of therapeutic coagulation in this group of patients. We herein present a unique case of a confirmed COVID-19 patient with metastatic ovarian cancer who presented with DVT and PE despite being on therapeutic anticoagulation, highlighting the unpredictability of COVID-19 associated coagulopathy. This case study raises the awareness that the thrombophilic state in metastatic malignancies is potentially augmented by COVID-19. We also discuss the complexity of making anticoagulation treatment decision in COVID-19 patients in the absence of evidence-based guidelines. ?COVID-19 Associated Coagulopathy in the Setting of Underlying Malignan(epmc).pdf DeepDyve Pubget Overpricing